A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Danaher Corp stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 5,215 shares of DHR stock, worth $1.19 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
5,215
Previous 4,098 27.26%
Holding current value
$1.19 Million
Previous $1.02 Million 41.64%
% of portfolio
0.4%
Previous 0.3%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$239.25 - $280.76 $267,242 - $313,608
1,117 Added 27.26%
5,215 $1.45 Million
Q2 2024

Aug 15, 2024

BUY
$235.51 - $267.98 $105,508 - $120,055
448 Added 12.27%
4,098 $1.02 Million
Q1 2024

May 15, 2024

BUY
$224.58 - $256.19 $469,596 - $535,693
2,091 Added 134.12%
3,650 $911,000
Q4 2023

Jan 31, 2024

BUY
$185.1 - $233.13 $55,715 - $70,172
301 Added 23.93%
1,559 $360,000
Q3 2023

Nov 09, 2023

BUY
$233.08 - $265.59 $280,861 - $320,035
1,205 Added 2273.58%
1,258 $312,000
Q2 2023

Aug 08, 2023

SELL
$224.99 - $256.14 $3,149 - $3,585
-14 Reduced 20.9%
53 $12,000
Q1 2023

Jun 20, 2023

SELL
$239.75 - $277.0 $5,993 - $6,925
-25 Reduced 27.17%
67 $16,000
Q4 2022

Mar 02, 2023

SELL
$241.42 - $282.29 $6,518 - $7,621
-27 Reduced 22.69%
92 $24,000
Q3 2022

Nov 15, 2022

BUY
$247.06 - $1507.4 $7,164 - $43,714
29 Added 32.22%
119 $31,000
Q2 2022

Aug 16, 2022

BUY
$237.11 - $299.66 $2,371 - $2,996
10 Added 12.5%
90 $23,000
Q1 2022

Jun 17, 2022

BUY
$257.27 - $315.76 $20,581 - $25,260
80 New
80 $22,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $166B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Oliver Lagore Vanvalin Investment Group Portfolio

Follow Oliver Lagore Vanvalin Investment Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oliver Lagore Vanvalin Investment Group, based on Form 13F filings with the SEC.

News

Stay updated on Oliver Lagore Vanvalin Investment Group with notifications on news.